当前位置: 首页 >> 检索结果
710. Rituximab for Relapsing Nephrotic Syndrome in Adults: A Randomized Clinical Trial.
作者: Yoshitaka Isaka.;Yusuke Sakaguchi.;Maki Shinzawa.;Shoichi Maruyama.;Mika Sakaguchi.;Hiroki Hayashi.;Yusuke Kaida.;Shin Goto.;Tatsuo Tsukamoto.;Akito Maeshima.;Yoichiro Ikeda.;Norihiko Sakai.;Naoki Sawa.;Kengo Furuichi.;Kunihiro Yamagata.;Takehiko Wada.;Yugo Shibagaki.;Keiju Hiromura.
来源: JAMA. 2025年334卷22期2011-2019页
The effects of rituximab on relapse of nephrotic syndrome in patients with adult-onset frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS) remain uncertain.
715. Toward a Safer World by 2040: The JAMA Summit Report on Reducing Firearm Violence and Harms.
作者: Frederick P Rivara.;Therese S Richmond.;Stephen Hargarten.;Charles C Branas.;Ali Rowhani-Rahbar.;Daniel Webster.;Joseph Richardson.;John Z Ayanian.;DeVone Boggan.;Anthony A Braga.;Shani A L Buggs.;Magdalena Cerdá.;Frederick Chen.;Anil Chitkara.;Dimitri A Christakis.;Cassandra Crifasi.;Lindsay Dawson.;Terri A deRoon-Cassini.;Rochelle Dicker.;Sheena Erete.;Sandro Galea.;David Hemenway.;Nancy La Vigne.;Adam Seth Levine.;Jens Ludwig.;Nason Maani.;Roger L McCarthy.;Desmond U Patton.;Jonathan D Quick.;Megan L Ranney.;Eszter Rimanyi.;Joseph S Ross.;Joseph V Sakran.;Robert J Sampson.;Zirui Song.;Jennifer Tucker.;Michael R Ulrich.;Laura Vargas.;Robert B Wilcox.;Nick Wilson.;Marc A Zimmerman.; .
来源: JAMA. 2025年334卷24期2208-2219页
Since the start of the 21st century, more than 800 000 firearm deaths and more than 2 million firearm injuries have occurred in the US. All categories of firearm violence-homicide, suicide, unintentional-result in reverberating harms to individuals, families, communities, and society. The collective responsibility of society is to safeguard the health and safety of its members, including from firearm harms. The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart an innovations roadmap that will lead to substantial reductions in firearm harms by 2040.
|